Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
113,738,083
-
Share change
-
-343,102
-
Total reported value
-
$144,445,790
-
Put/Call ratio
-
4.6%
-
Price per share
-
$1.27
-
Number of holders
-
127
-
Value change
-
-$76,640,644
-
Number of buys
-
59
-
Number of sells
-
88
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q3 2023
As of 30 Sep 2023,
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,738,083 shares.
The largest 10 holders included
EcoR1 Capital, LLC, VR Adviser, LLC, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., VANGUARD GROUP INC, Bellevue Group AG, Balyasny Asset Management L.P., SILVERARC CAPITAL MANAGEMENT, LLC, Rock Springs Capital Management LP, and Affinity Asset Advisors, LLC.
This page lists
127
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.